538 related articles for article (PubMed ID: 16944543)
1. Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines.
Zsoldos-Mády V; Csámpai A; Szabó R; Mészáros-Alapi E; Pásztor J; Hudecz F; Sohár P
ChemMedChem; 2006 Oct; 1(10):1119-25. PubMed ID: 16944543
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, electrochemical studies and antitumor activity of some new chalcone analogues containing ferrocenyl pyrazole moiety.
Ratković Z; Juranić ZD; Stanojković T; Manojlović D; Vukićević RD; Radulović N; Joksović MD
Bioorg Chem; 2010 Feb; 38(1):26-32. PubMed ID: 19846191
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl)amino]chalcones and hydrazine as potential antitumor and antimalarial agents.
Insuasty B; Montoya A; Becerra D; Quiroga J; Abonia R; Robledo S; Vélez ID; Upegui Y; Nogueras M; Cobo J
Eur J Med Chem; 2013 Sep; 67():252-62. PubMed ID: 23871905
[TBL] [Abstract][Full Text] [Related]
6. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
7. Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives.
Farag AM; Mayhoub AS; Barakat SE; Bayomi AH
Bioorg Med Chem; 2008 Jan; 16(2):881-9. PubMed ID: 17962022
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents.
Bhat BA; Dhar KL; Puri SC; Saxena AK; Shanmugavel M; Qazi GN
Bioorg Med Chem Lett; 2005 Jun; 15(12):3177-80. PubMed ID: 15893928
[TBL] [Abstract][Full Text] [Related]
9. Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents.
Sivakumar PM; Ganesan S; Veluchamy P; Doble M
Chem Biol Drug Des; 2010 Nov; 76(5):407-11. PubMed ID: 20925692
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective synthesis of ferrocenyl nucleoside analogues with apoptosis-inducing activity.
James P; Neudörfl J; Eissmann M; Jesse P; Prokop A; Schmalz HG
Org Lett; 2006 Jun; 8(13):2763-6. PubMed ID: 16774251
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationship studies of furan-ring fused chalcones as antiproliferative agents.
Saito Y; Kishimoto M; Yoshizawa Y; Kawaii S
Anticancer Res; 2015 Feb; 35(2):811-7. PubMed ID: 25667461
[TBL] [Abstract][Full Text] [Related]
13. The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif.
Hillard EA; Pigeon P; Vessières A; Amatore C; Jaouen G
Dalton Trans; 2007 Nov; (43):5073-81. PubMed ID: 17992292
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
16. New ferrocene containing peptide conjugates: synthesis and effect on human leukemia (HL-60) cells.
Miklán Z; Szabó R; Zsoldos-Mády V; Reményi J; Bánóczi Z; Hudecz F
Biopolymers; 2007; 88(2):108-14. PubMed ID: 17266125
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives.
Congiu C; Onnis V; Vesci L; Castorina M; Pisano C
Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096
[TBL] [Abstract][Full Text] [Related]
19. Antiplasmodial activity of ferrocenyl chalcones: investigations into the role of ferrocene.
Wu X; Tiekink ER; Kostetski I; Kocherginsky N; Tan AL; Khoo SB; Wilairat P; Go ML
Eur J Pharm Sci; 2006 Feb; 27(2-3):175-87. PubMed ID: 16269240
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
Aponte JC; Verástegui M; Málaga E; Zimic M; Quiliano M; Vaisberg AJ; Gilman RH; Hammond GB
J Med Chem; 2008 Oct; 51(19):6230-4. PubMed ID: 18798609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]